Reducing stigma and improving perception of Leprosy in Togo: From roadmap to effective intervention practices

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00029355

Enrollment

1200

Registered

2022-09-06

Start date

2023-03-09

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A30.9

Interventions

Group 1: control group: no campaign These villages do not receive any intervention before the endline Datacollection. Group 2: In randomly selected villages, educational campaigns are carried out acco

Eligibility

Sex/Gender

All

Age

18 Years to 120 Years

Inclusion criteria

Inclusion criteria: Population living in leprosy, Buruli or Yaws highly endemic villages in Togo with diagnosed cases of the disease within the last 5 years

Exclusion criteria

Exclusion criteria: no informed consent

Design outcomes

Primary

Measure	Time frame
1. Change scores of knowledge measured by a Knowledge, Attitudes and Practices (KAP) test 2. Change scores of social distance measured by a 7-item Social Distance Scale (SDS) 3. Change scores of perceived stigma measured by a 15-item Explanatory Model Interview Catalogue (EMIC) stigma scale for the community	—

Secondary

Measure	Time frame
1. Change scores of impact of stigma measured by a 13-item Participation Scale (P-scale) 2. Change scores of experienced, internalised and anticipated stigma and disclosure concerns neasured by a 21-item Stigma Assessment and Reduction of Impact (SARI) Stigma Scale 3. Change scores of experiences stigma measured by a 5-Question Stigma Indicators (5-QSI-AP) 4. Change scores of anxiety and depression, social dysfunction, and loss of confidence measured by 12-item General Health Questionnaire (GHQ-12) 5. Change scores of social isolation and loneliness measured by 3-item UCLA Loneliness Scale (ULS-3) 6. Change scores of optimistic self-beliefs to cope with a variety of difficult demands in life measured by 10-item General Self-efficacy Scale (GSE-10) 7. Change scores of positive and negative feelings about the self measured by a 10-item Rosenberg Self-Esteem Scale (RSE)	—

Measure

Time frame

1. Change scores of impact of stigma measured by a 13-item Participation Scale (P-scale) 2. Change scores of experienced, internalised and anticipated stigma and disclosure concerns neasured by a 21-item Stigma Assessment and Reduction of Impact (SARI) Stigma Scale 3. Change scores of experiences stigma measured by a 5-Question Stigma Indicators (5-QSI-AP) 4. Change scores of anxiety and depression, social dysfunction, and loss of confidence measured by 12-item General Health Questionnaire (GHQ-12) 5. Change scores of social isolation and loneliness measured by 3-item UCLA Loneliness Scale (ULS-3) 6. Change scores of optimistic self-beliefs to cope with a variety of difficult demands in life measured by 10-item General Self-efficacy Scale (GSE-10) 7. Change scores of positive and negative feelings about the self measured by a 10-item Rosenberg Self-Esteem Scale (RSE)

—

Countries

Togo

Contacts

Public ContactBayaki SAKA

Service de dermatologie, CHU S. OlympioFaculté des Sciences de la Santé, Université de Lomé

barthelemysaka@yahoo.fr+22897368855

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026